ValueBuddies.com : Value Investing Forum - Singapore, Hong Kong, U.S.

Pages (795): « Previous 1 … 499 500 501 502 503 … 795 Next »

Date & Time	Title
Thu, 28 Nov 2024 16:27:00 +0800	New Canadian Distributor UNIVELO Announces Exclusive Distribution of AIMA E-Bikes in Canada
Thu, 28 Nov 2024 16:01:00 +0800	DAHON Gains Traction with "D-VELO"，Leading New Trends in Green Mobility-themed CCBI 2024
Thu, 28 Nov 2024 16:00:00 +0800	ARLO UNVEILS ALL-NEW WIRED FLOODLIGHT CAMERA FOR ULTIMATE OUTDOOR PROTECTION IN AUSTRALIA
Thu, 28 Nov 2024 15:40:00 +0800	Xinhua Silk Road: Wuxi Economic Development Zone makes efforts to optimize business environment
Thu, 28 Nov 2024 15:27:00 +0800	Biwatt Showcases Advanced Sodium-ion Energy Solutions at Solar Solutions Düsseldorf
Thu, 28 Nov 2024 15:26:00 +0800	Xinhua Silk Road: Multiple achievements made at promotion conference held in Shanghai
Thu, 28 Nov 2024 14:59:00 +0800	Sungrow and Smart Commercial Solar Partner to Build Sustainable Energy Infrastructure for Leading Aged Care Provider, Opal HealthCare
Thu, 28 Nov 2024 14:31:00 +0800	Taiwan Tourism Administration Promotes Muslim-Friendly Tourism
Thu, 28 Nov 2024 14:21:00 +0800	Jiangsu in Focus: Bridging History and the Future Through High-Quality Development
Thu, 28 Nov 2024 13:50:00 +0800	Gravity Announces Global Release of Tokyo Psychodemic
Thu, 28 Nov 2024 13:46:00 +0800	Shanghai honors 50 expats with Magnolia Silver Awards
Thu, 28 Nov 2024 13:43:00 +0800	Everest Medicines Announces NEFECON®, the World's First Approved Treatment for IgA Nephropathy, is Included in China's National Reimbursement Drug List
Thu, 28 Nov 2024 13:43:00 +0800	Shanghai honors 50 expats with Magnolia Silver Awards
Thu, 28 Nov 2024 13:04:00 +0800	Antengene Announces XPOVIO®'s New Indication Included in 2024 China National Reimbursement Drug List, Making the Drug More Accessible to DLBCL Patients in the Country
Thu, 28 Nov 2024 13:00:00 +0800	ASSEMBLY ELEVATES VIVIAN MOK TO SVP & MANAGING DIRECTOR FOR NORTH ASIA
Thu, 28 Nov 2024 12:07:00 +0800	Innovent Announces First-Time Inclusion of SINTBILO® and New Indication for Olverembatinib in China's National Reimbursement Drug List
Thu, 28 Nov 2024 12:00:00 +0800	Team T5 Applauded by Frost & Sullivan for Deeply and Effectively Monitoring Regional Adversaries and Incidents
Thu, 28 Nov 2024 11:58:00 +0800	Akeso Announced the Inclusion in China's National Reimbursement Drug List of Cadonilimab and Ivonescimab
Thu, 28 Nov 2024 11:44:00 +0800	Hangzhou Hosts Second Liangzhu Forum with Global Cultural Leaders
Thu, 28 Nov 2024 11:40:00 +0800	Global Times: Dialogue across Yangtze, Rhine, Danube bridges mutual learning between China and Europe

Pages (795): « Previous 1 … 499 500 501 502 503 … 795 Next »

Login
Username:
Password:	Lost Password?
	Remember me